Actionable news
All posts from Actionable news
Actionable news in ALXN: Alexion Pharmaceuticals, Inc.,

Alexion Pharmaceuticals (ALXN) David Hallal on Q3 2015 Results - Earnings Call Transcript


Good morning and welcome to the Alexion Pharmaceuticals Incorporated Third Quarter 2015 Results Conference Call. Today's call is being recorded. For opening remarks and introductions, I would like to turn the call over to Ms. Elena Ridloff, Executive Director-Investor Relations. Please go ahead, ma'am.

Elena Ridloff - Investor Relations

Thank you, Trisha. Good morning and thank you for joining us on today's call to discuss Alexion's performance for the third quarter of 2015 and updated plans for the full year. Today's call will be led by David Hallal, our CEO. David will start the call with an overview of our global performance and be joined by Vikas Sinha, our Chief Financial Officer; and Carsten Thiel, our Chief Commercial Officer as well as Martin MacKay, our Global Head of R&D. Also with us today are Saqib Islam, our Chief Strategy and Portfolio Officer and Julie O'Neill, our Global Head of Operations. You can access the webcast live, that will be presented on this call, by going to the Events section of our Investor Relations page on our website.

Before we begin, I will refer you to Slide 3. We will make forward-looking statements, all of...